Angiotensin converting enzyme inhibitors in acute myocardial infarction

Grzegorz Opolski; Krzysztof J. Filipiak; Marcin Grabowski

Abstract

2/2005 vol. 8

Angiotensin converting enzyme inhibitors in acute myocardial infarction

Grzegorz Opolski

,

Krzysztof J. Filipiak

,

Marcin Grabowski

Przew Lek 2005, 2:40-47

Online publish date: 2005/04/13

View full text

AMA

Opolski G, J. Filipiak K, Grabowski M. Angiotensin converting enzyme inhibitors in acute myocardial infarction. Przewodnik Lekarza/Guide for GPs. 2005:40-47.

APA

Opolski, G., J. Filipiak, K., & Grabowski, M. (2005). Angiotensin converting enzyme inhibitors in acute myocardial infarction. Przewodnik Lekarza/Guide for GPs, 40-47.

Chicago

Opolski, Grzegorz, Krzysztof J. Filipiak, and Marcin Grabowski. 2005. "Angiotensin converting enzyme inhibitors in acute myocardial infarction". Przewodnik Lekarza/Guide for GPs: 40-47.

Harvard

Opolski, G., J. Filipiak, K., and Grabowski, M. (2005). Angiotensin converting enzyme inhibitors in acute myocardial infarction. Przewodnik Lekarza/Guide for GPs, pp.40-47.

MLA

Opolski, Grzegorz et al. "Angiotensin converting enzyme inhibitors in acute myocardial infarction." Przewodnik Lekarza/Guide for GPs, 2005, pp. 40-47.

Vancouver

Opolski G, J. Filipiak K, Grabowski M. Angiotensin converting enzyme inhibitors in acute myocardial infarction. Przewodnik Lekarza/Guide for GPs. 2005:40-47.

Most randomized, placebo-controlled trials have demonstrated that angiotensin converting enzyme (ACE) inhibitors started early in acute myocardial infarction improves left ventricular function and prognosis after myocardial infarction. This article summaries current knowledge and recommendation for use ACE inhibitors acute myocardial infarction.

Keywords

angiotensin converting enzyme inhibitors, acute myocardial infarction

Integrated with